| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) | 
|---|
| 02/13/2014 | US20140045813 Heteroaromatic compounds as btk inhibitors | 
| 02/13/2014 | US20140045802 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use | 
| 02/12/2014 | EP2695882A1 Organic compound, charge transport material, composition containing said compound, organic electroluminescent element, display device, and lighting device | 
| 02/12/2014 | EP2694619A1 Novel organic electroluminescent compounds and an organic electroluminescent device using the same | 
| 02/12/2014 | EP2694484A1 Pyrimidine derivatives for the treatment of viral infections | 
| 02/12/2014 | EP2694482A1 Wnt pathway antagonists | 
| 02/12/2014 | EP2694481A1 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents | 
| 02/12/2014 | EP2694060A1 Substituted 3-(1h-benzo{d}imidazol-2-yl)-1h-indazole-analogs as inhibitors of the pdk1 kinase | 
| 02/12/2014 | CN103582637A Inhibitors of bruton's tyrosine kinase | 
| 02/12/2014 | CN103582636A (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases | 
| 02/12/2014 | CN103582632A 取代的苯并咪唑 Substituted benzimidazoles | 
| 02/12/2014 | CN103582629A 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/2-pyrimidine-carborxamides as MGLUR5 modulators | 
| 02/12/2014 | CN103582482A Pharmaceutically active disubstituted triazine derivatives | 
| 02/12/2014 | CN103570704A Quinazoline derivative with oxazolidinone ring side chain as well as preparation and application | 
| 02/12/2014 | CN103570693A Bridged compound serving as hepatitis C inhibitor and application of bridged compound in medicines | 
| 02/12/2014 | CN103570692A Quinazoline derivative with ethylene imine ring side chain as well as preparation and application | 
| 02/12/2014 | CN103570691A Chiral pyrrolidine functionalized imidazolium salt, and preparation method and application thereof | 
| 02/12/2014 | CN103570690A Salt of imidazolidone derivatives | 
| 02/12/2014 | CN103570688A 2,5-diaminomethylpyrazine compounds, drug compositions, preparation method and use thereof | 
| 02/12/2014 | CN103570630A Heterocyclic nitrogen derivative and application thereof in medicines | 
| 02/12/2014 | CN103570629A Benzanthracene derivatives containing pyrimidinyl, pyrazinyl or triazinyl groups and applications thereof | 
| 02/12/2014 | CN103570628A Benzoindenofluorene derivative containing pyrimidyl or pyrazinyl or triazinyl group, and its application | 
| 02/12/2014 | CN103570627A Indenofluorene derivative containing pyrimidyl or pyrazinyl or triazinyl group, and its application | 
| 02/12/2014 | CN103570625A N-(3-aryl-heteroaryl)-4-aryl-aryl carboxamide and analog as hedgehog pathway inhibitors and application thereof | 
| 02/12/2014 | CN102906086B Quinazoline compounds | 
| 02/12/2014 | CN102816150B Indole with bacteriostatic activity and derivatives thereof-triazole compounds, and preparation method thereof | 
| 02/12/2014 | CN102596937B Compounds and compositions as protein kinase inhibitors | 
| 02/12/2014 | CN102093282B 肟酯光敏引发剂 Oxime ester photoinitiator | 
| 02/12/2014 | CN102015634B Pesticides | 
| 02/11/2014 | US8648094 IAP BIR domain binding compounds | 
| 02/11/2014 | US8648088 Ethynyl nitrogen containing heteroaryl pyrazolidin-3-one derivatives | 
| 02/11/2014 | US8648069 5-substituted indazoles as kinase inhibitors | 
| 02/11/2014 | US8648067 Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligands | 
| 02/11/2014 | CA2646678C Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 | 
| 02/11/2014 | CA2536622C Inhibitors of cellular necrosis | 
| 02/11/2014 | CA2511199C Small molecule modulators of hepatocyte growth factor (scatter factor) activity | 
| 02/11/2014 | CA2501506C Modulation of anxiety through blockade of anandamide hydrolysis | 
| 02/06/2014 | WO2014022858A1 Enzyme-activating compounds and compositions | 
| 02/06/2014 | WO2014022728A1 Substituted 5 - (quinazolin - 2 - yl) pyrimidin- 2 -amine derivatives useful as pi3k/mtor inhibitors for the treatment of cancer | 
| 02/06/2014 | WO2014022382A2 Antibacterial protein kinase inhibitors | 
| 02/06/2014 | WO2014022343A1 7-hydroxy-indolinyl antagonists of p2y1 receptor | 
| 02/06/2014 | WO2014021591A2 Novel compound, method for preparing same and pharmaceutical composition comprising same | 
| 02/06/2014 | WO2014020012A1 Quinone compounds and their uses for the treatment of cancer | 
| 02/06/2014 | WO2014019344A1 Bridged ring compounds as hepatitis c virus (hcv) inhibitors and pharmaceutical applications thereof | 
| 02/06/2014 | WO2014019338A1 Protein kinase inhibitors | 
| 02/06/2014 | WO2014019179A1 Method for preparing telaprevir and intermediate thereof | 
| 02/06/2014 | WO2014019092A1 Inhibitors of peptidyl arginine deiminase (pad) enzymes and uses thereof | 
| 02/06/2014 | US20140039189 Novel process for the preparation of acylguanidines and acylthioureas | 
| 02/06/2014 | US20140039021 Antiviral compounds | 
| 02/06/2014 | US20140038993 New compounds | 
| 02/06/2014 | US20140038990 Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease | 
| 02/06/2014 | US20140038987 SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS | 
| 02/06/2014 | US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase | 
| 02/06/2014 | US20140038975 Imidazole, Pyrazole, and Triazole Derivatives Useful As Antibacterial Agents | 
| 02/06/2014 | US20140038968 Amino-heteroaryl-containing prokineticin 1 receptor antagonists | 
| 02/06/2014 | US20140038964 Imidazole based lxr modulators | 
| 02/06/2014 | US20140038958 Cdk8-cdk19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer | 
| 02/06/2014 | US20140038952 Substituted Amino-Pyrimidine Derivatives | 
| 02/06/2014 | US20140038947 Therapeutic applications of pro-apoptotic benzodiazepines | 
| 02/06/2014 | US20140038945 Piperazine pde4 inhibitors and uses thereof | 
| 02/06/2014 | US20140038943 Serotonin receptor modulator | 
| 02/06/2014 | US20140038938 Substituted dihydropyrazolones and their use | 
| 02/06/2014 | US20140037754 Aminopyrimidines useful as kinase inhibitors | 
| 02/05/2014 | EP2692726A1 Anti-viral compounds | 
| 02/05/2014 | EP2691390A1 Process for the preparation of 1 - ( 2 -methyl - 4 - ( 2, 3, 4, 5 - tetrahydro - 1 - benzazepin- 1 -ylcarbonyl) benzylcarbamoyl) - l - proline - n, n- dimethylamide | 
| 02/05/2014 | EP2691389A1 (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases | 
| 02/05/2014 | EP2691388A1 (fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases | 
| 02/05/2014 | EP2691384A1 (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases | 
| 02/05/2014 | EP2691375A1 Substituted benzimidazoles | 
| 02/05/2014 | EP2691095A2 Imidazolyl amide compounds and uses related thereto | 
| 02/05/2014 | EP2690957A1 Penoxsulam as an herbicide in alfalfa | 
| 02/05/2014 | CN103562203A Process for the preparation of 1-(2-methyl-4-(2, 3, 4, 5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L- proline-N, N- dimethylamide | 
| 02/05/2014 | CN103562202A BCL-2/BCL-XL inhibitors and therapeutic methods using the same | 
| 02/05/2014 | CN103562201A Substituted benzoazepines as TOLL-like receptor modulators | 
| 02/05/2014 | CN103562200A Novel imidazole derivatives useful for the treatment of arthritis | 
| 02/05/2014 | CN103562191A Nitrogen-containing saturated heterocyclic compound | 
| 02/05/2014 | CN103562186A Substituted benzoazepines as toll-like receptor modulators | 
| 02/05/2014 | CN103561772A Immunoconjugates, compositions containing them, and methods of making and use | 
| 02/05/2014 | CN103554089A Diheterocyclic compound as well as synthesis method and application thereof | 
| 02/05/2014 | CN103554042A Triazole compounds that modulate hsp90 activity | 
| 02/05/2014 | CN103554006A Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease | 
| 02/05/2014 | CN103551193A N2 substituted 1,2,3-triazole ligand/Cu(I) composite catalyst, as well as synthesis and applications thereof | 
| 02/04/2014 | US8642642 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor | 
| 02/04/2014 | US8642628 Pyrrole inhibitors of S-nitrosoglutathione reductase | 
| 02/04/2014 | US8642626 Ethinyl-pyrazole derivative | 
| 02/04/2014 | US8642611 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same | 
| 02/04/2014 | US8642609 Modulators of ATP-binding cassette transporters | 
| 02/04/2014 | US8642585 Indanyloxydihydrobenzofuranylacetic acids | 
| 02/04/2014 | US8642580 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and platinum derivatives | 
| 02/04/2014 | US8642025 Hepatitis C virus inhibitors | 
| 02/04/2014 | CA2491191C Receptor-type kinase modulators and methods of use | 
| 01/30/2014 | WO2014017643A1 Difluoromethylene compound | 
| 01/30/2014 | WO2014017569A1 Pharmaceutical product for lowering blood ldl | 
| 01/30/2014 | WO2014017342A1 Indole derivative or pharmacologically acceptable salt thereof | 
| 01/30/2014 | WO2014017094A1 Organic electroluminescence element | 
| 01/30/2014 | WO2014015931A1 Materials for organic electroluminescent devices | 
| 01/30/2014 | WO2008019124A8 Heteroaryl compounds useful as inhibitors of e1 activating enzymes | 
| 01/30/2014 | US20140031368 Selective hdac inhibitors | 
| 01/30/2014 | US20140031365 Use of a polymorph of flibanserin for treating disease | 
| 01/30/2014 | US20140031361 Inhibitors of protein kinases |